10-Q: Doximity Reports Strong Q3 Growth, Revenue Up 25% Year-Over-Year

Doximity's Q3 2025 results show a 25% increase in revenue compared to the same period last year, driven by subscription growth.

Summary

• Doximity's Q3 2025 revenue reached $168.6 million, a 25% increase year-over-year.
• Subscription revenue was the primary driver, increasing by $32.8 million.
• Net income for the quarter was $75.2 million, compared to $48.0 million in Q3 2024.
• Adjusted EBITDA for Q3 2025 was $102.0 million, with a margin of 61%.
• The company's customer base with trailing 12-month subscription revenue greater than $500,000 grew to 114, accounting for approximately 84% of revenue.
• The net revenue retention rate was 117%.
• For the nine months ended December 31, 2024, revenue was $432.1 million, a 21% increase year-over-year.
• Net income for the nine months was $160.7 million, and adjusted EBITDA was $244.1 million.
• The company repurchased and retired 1,416,104 shares of Class A common stock for $49.2 million, with $450.8 million remaining authorized for repurchase.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong revenue growth and profitability. While there are some risks and increased expenses, the overall tone is optimistic.

Positives

• Strong revenue growth driven by subscription services.
• Increased net income and adjusted EBITDA.
• High net revenue retention rate indicates customer satisfaction and loyalty.
• Continued share repurchase program demonstrates confidence in the company's value.
• Growth in the number of high-value customers (>$500,000 revenue).

Negatives

• Increased operating expenses, particularly in research and development, sales and marketing, and general and administrative areas.
• A $2.3 million impairment charge was recognized on property and equipment in connection with a sublease.
• Net outflow from operating assets and liabilities due to timing of billings and collections.

Risks

• The company is involved in securities litigation and shareholder derivative lawsuits.
• The company's future capital requirements will depend on many factors, including revenue growth rate, the timing and the amount of cash received from customers, the expansion of sales and marketing activities, timing of share repurchases, and the timing and extent of spending to support research and development efforts.
• The company may not be able to fully offset higher costs if they were to become subject to significant inflationary pressures.

Future Outlook

The company believes that its existing cash and cash equivalents and marketable securities will be sufficient to support working capital and capital expenditure requirements for at least the next 12 months.

Management Comments

• Our mission is to help every physician be more productive and provide better care for their patients.
• We are physicians-first, putting technology to work for doctors instead of the other way around.

Industry Context

Doximity operates in the healthcare technology sector, providing a platform for medical professionals to connect, collaborate, and access relevant information. The company's growth reflects the increasing adoption of digital solutions in the healthcare industry.

Comparison to Industry Standards

• Doximity's 117% net revenue retention rate is strong compared to other SaaS companies, such as Veeva Systems, which focuses on the pharmaceutical industry.
• The company's adjusted EBITDA margin of 61% is also competitive within the industry, suggesting efficient operations.
• Compared to Teladoc Health, which provides virtual healthcare services, Doximity's focus on providing a professional network and tools for physicians differentiates it in the market.

Legal Proceedings

• The Company and certain of our directors and officers have been named in lawsuits in the United States District Court for the Northern District of California.
• The operative complaint brings securities law claims on behalf of a putative class of our investors from June 24, 2021 and August 8, 2023 against the Company and our CEO related to our disclosure of user count and engagement rates.
• Three shareholder derivative lawsuits have also been filed asserting claims for, among other things, violations of securities law, breach of fiduciary duties, unjust enrichment, abuse of control, gross mismanagement, and waste against certain of our directors and officers on a similar basis to the securities lawsuit.

Stakeholder Impact

• Shareholders: Positive results may lead to increased stock value.
• Employees: Continued growth may lead to job security and potential for career advancement.
• Customers: Continued investment in the platform may lead to improved services and solutions.

Key Dates